The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for ...

Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with ...

The European Commission (EC) will restrict Chinese firms from EU government purchases of medical devices exceeding €5m ($5.7m ...

GE HealthCare has announced the renewal of its research partnership with Stanford Medicine, US, focusing on the PET/CT ...

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

Penumbra stands to maintain its market lead and possibly increase its market share as the purchasing of the Ruby XL system ...

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...

GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, ...

Beset by seemingly endless responsibilities, within the UK's NHS and other healthcare systems globally, burnout among GPs is ...

Qiagen, Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of ...

Visby Medical has secured around $55m in its funding round to expedite the launch and distribution of its at-home Women's ...

Exo has obtained 510(k) clearance for two AI-based apps that detect two common lung conditions with its Exo Iris POCUS device ...